Drug's lasting benefits sees breast cancer deaths down by third
Oxford researchers used data from 20 trials comparing tamoxifen use for five years against no tamoxifen. Credit: US National Cancer Institute
The benefits of using tamoxifen to prevent recurrence of breast cancer after surgery continue to accrue long after women stop taking the drug, a study led by Oxford University has found.
The findings suggest that for women with the most common type of breast cancer, full compliance with daily tamoxifen therapy for five years would reduce the long-term chances of dying by at least a third.
"Breast cancer is a nasty disease because it can come back years later," says Dr. Christina Davies of the Clinical Trial Service Unit at Oxford University, and one of the lead investigators. "This study now shows that tamoxifen produces really long-term protection.
Most breast cancers are oestrogen receptor (ER)-positive in the US or UK, its about 4 out of 5 breast cancers that are ER-positive.
Since tamoxifen acts on the ER protein in breast cancer cells, it can have an effect only if those cells contain some ER protein. But a simple test on surgically removed breast cancers can determine whether the cancer is ER-positive or not.
Various treatments can be given after apparently successful breast cancer surgery to prevent any tiny residual fragments eventually causing the cancer to come back as an incurable disease.
Many randomized trials have been conducted to try to determine the best treatment options, and every 5 years for the past 25 years the Early Breast Cancer Trialists Collaborative Group (EBCTCG) has brought together all the evidence from all of these trials.
In the current study, funded by Cancer Research UK, the Medical Research Council and the British Heart Foundation, the researchers brought together individual patient data for over 20,000 women with early-stage breast cancer from 20 randomised trials. The trials compared treatment with tamoxifen for 5 years against no tamoxifen, with participants showing 80% compliance in taking the daily pill.
Most of the trials of tamoxifen began in the 1980s, meaning there is now lots of data available on the long-term effects of treatment after women stopped taking the drug. That long-term analysis, published in the Lancet medical journal, now reveals large additional benefits of tamoxifen in reducing breast cancer deaths, not only during the first decade but also during the second decade after treatment began.
The researchers found that in women with ER-positive disease, 5 years of daily tamoxifen safely reduced the long-term (15-year) risks of breast cancer recurrence and death. It was effective whether or not chemotherapy had been given.
Remarkably, the researchers found a highly significant reduction in breast cancer mortality, not only during the five years of treatment and the five years following, but also during years 1014.
Even in weakly ER positive disease, tamoxifen substantially reduced the likelihood of the cancer recurring.
There is a newer class of drugs called aromatase inhibitors (AIs) that offer an alternative to tamoxifen for some patients, but AIs are effective only in post-menopausal women.
Dr. Davies explains that tamoxifen was developed 50 years ago and is long out of patent, so is relatively cheap. But even if costs are ignored it remains a major first-line treatment option for women with ER-positive breast cancer, she says especially for women pre-menopause.
Moreover, the rare life-threatening side-effects of tamoxifen (uterine cancer and blood clots) are mainly experienced by women over 55 years of age, so there is little risk from giving tamoxifen to younger women.
Worldwide, half of all new patients diagnosed with breast cancer are younger than 55 years thats 0.7 million women.
More information: doi:10.1016/S0140-6736(11)60993-8
Provided by Oxford University
- Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer Aug 25, 2009 | not rated yet | 0
- Goserelin improves long-term survival in premenopausal women with early breast cancer Feb 24, 2009 | not rated yet | 0
- Tamoxifen chemoprevention tied to early detection of breast cancer Oct 07, 2008 | not rated yet | 0
- Novel basis identified for tamoxifen failure Dec 04, 2008 | not rated yet | 0
- Taking tamoxifen to prevent breast cancer can save lives and money Mar 14, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer 3 hours ago | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer 3 hours ago | not rated yet | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer 6 hours ago | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer 7 hours ago | 5 / 5 (1) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer 7 hours ago | 5 / 5 (3) | 0
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
1 hour ago | 5 / 5 (1) | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
1 hour ago | not rated yet | 0
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
7 hours ago | 5 / 5 (3) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
4 hours ago | 5 / 5 (1) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
4 hours ago | 5 / 5 (2) | 0 |
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
22 hours ago | 4.9 / 5 (9) | 0 |